Latest Breaking News On - Leerink partners - Page 2 : comparemela.com

Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering

SAN FRANCISCO, June 05, 2024 Structure Therapeutics Inc. , a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary.

United statesNew yorkDan budwickDanielle keatleyEquity syndicate prospectus departmentMorgan stanley coSyndicate departmentEquity syndicate departmentStructure therapeutics incGuggenheim securitiesExchange commissionCapital markets corpMorgan stanleyProspectus departmentGoldman sachs coStructure therapeutics

Structure Therapeutics (GPCR) Announces Pricing of Upsized $476 Million Public Offering

Structure Therapeutics (GPCR) Announces Pricing of Upsized $476 Million Public Offering
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkMorgan stanleyMorgan stanley coGuggenheim securitiesExchange commissionLeerink partnersGoldman sachs coEquity syndicate prospectus departmentSyndicate departmentProspectus departmentCapital markets corpStructure therapeutics incEquity syndicate departmentStructure therapeuticsGoldman sachs

Bionomics : SECURITIES PURCHASE AGREEMENT - Form 6-K

SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT is made and entered into as of May 31, 2024 by and among Bionomics Limited, a public company incorporated under.

United statesNew yorkNew york stock exchangeCommonwealth of australiaSpyros papapetropoulosTheodorej ghorraNeither the companyGood laboratory practiceGroup incCompany counselInternational accounting standards boardCompany the first closing subscription amountLeerink partnersCompany constitutionFinancial action task force on money launderingAgreements of the company

ASCO: Gilead looks for silver lining in Trodelvy s failed lung cancer trial But will the FDA play ball?

ASCO: Gilead looks for silver lining in Trodelvy s failed lung cancer trial But will the FDA play ball?
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

United statesDaiichi sankyoBilal piperdiGilead sciencesAmerican society of clinical oncologyAmerican societyClinical oncologyLeerink partners

Pfizer lung cancer drug shows promising long-term trial results

Pfizer lung cancer drug shows promising long-term trial results
cnbc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cnbc.com Daily Mail and Mail on Sunday newspapers.

United statesAndrew berensChris boshoffDavid spigelAmerican society of clinical oncologySarah cannon research instituteAmerican societyClinical oncologyLeerink partners